the aid library

LIST OPTIONS

Filter

10240

The Best Oatmeal for Type 2 Diabetes

Cherney, K.; Grieger, L. Everydayhealth Group (2022) CC2

The article "Best (and Worst) Oatmeal for Type 2 Diabetes" from Everyday Health discusses the benefits of incorporating oatmeal into a diabetes-friendly diet. It emphasizes that oatmeal, being rich in fiber and essential minerals like magnesium, pot... more

Maladies non transmissibles 2024

World Health Organization WHO; Eastern Mediterranean Region World Health Organization (WHO) (2024) C_WHO

The WHO Eastern Mediterranean Region's Noncommunicable Diseases (NCD) Data and Statistics page offers comprehensive information on NCD surveillance, including mortality rates, morbidity, and risk factor exposures. It emphasizes the importance ... monitoring NCD trends to inform prevention and control strategies, aligning with global targets such as reducing premature NCD deaths by one-third by 2030. The page also highlights the WHO STEPwise approach to NCD risk factor surveillance, providing standardized methods for data collection and analysis. more

External Link (212)

Overview | Asthma: diagnosis, monitoring and chronic asthma management | Guidance | NICE

National Institute for Health and Care Excellence (2017) CC

This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce th... more

Lung function tests in Asthma

Levin, M. National Asthma Education Programme (2012) CC2

Asthma is a very commom condition. It cannot be cured, but can controlled with effective medication, good technique, and good monitoring by the patients are having no or few symptoms, no attacks needingg hospital visits and no or little emergency reliever medication use. Another way ... assessing asthma control is to do tests that measure the function of your lungs. These tests are sometimes also done to help with the diagnosis of asthma. more

FAST Job Aid MDR-TB Settings

United States Agency for International Development (USAID) (2013)

This core package of materials provides a comprehensive introduction to the FAST strategy: a focused approach to stopping TB spread in congregate settings. In English, FAST stands for: Finding TB cases Actively, Separating safely, and T... more

FAST Poster TB Settings

United States Agency for International Development (USAID) (2013)

Responding to communicable and noncommunicable diseases: progress report 2020-2022

World Health Organization WHO (2023) C_WHO

Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration betw... more

External Link

Dengue Prevention Video

Scientific Animation without Borders SAWBO (2016) C1

This 3 minutes and 24 second animation describes Dengue transmission, infection and the different symptoms associated with this disease. Also, the animation gives additional information about the habits of... this mosquito. This video illustrates several important preventative measures, both inside the house and the environmental sanitation around the house, to avoid being bitten by the mosquitoes. Let's all work together to stop the spread of dengue! more

Download (447)

View PDF (473)

Manual for developing national malaria strategic plans

World Health Organization WHO, Regional Office for Africa (2019) C_WHO

The aim of the framework is to provide guidance to Member States and partners on region-specific priority actions towards the goals, targets and milestones of the GTS. The central pillar ... the framework is the adoption of programme phasing and transitioning, aimed at facilitating a tailored approach to malaria control/elimination. This is in response to the increasing heterogeneity of malaria epidemiology among and within countries of the region. more

Download (1184)

View PDF (1849)

MDR-TB Patient Education Flipchart

United States Agency for International Development (USAID) (2011)

For full publication see: https://drtbnetwork.org/mdr-tb-patient-education-flipchart This tool can be used to educate new patients about TB and MDR-TB. The healthcare provider should review the material together with the patient. A treatment supporter can also use this flipchart at community lev... more

Download (179)

View PDF (229)

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector devel...opment plans and the Health Sector Reform Strategy 2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download (1135)

View PDF (4493)

Zika Virus Infection: Step by Step Guide on Risk Communication and Community Engagement
recommended

Pan American Health Organization (2016) C_WHO

This document offers suggested risk communication actions in relation to Zika virus infection and other health issues linked to this disease. It is directed toward ministers of health and other heal... more

Download (2870)

View PDF (1959)

WHO Guidelines for malaria
recommended

World Health Organization (WHO) (2022) C_WHO

25 Nov 2022 The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform. The WHO Guidelines for malaria supersedes 2 previous WHO publications: the Guidelines for the treatment ... malaria, third edition and the Guidelines for malaria vector control. Recommendations on malaria will continue to be reviewed and, where appropriate, updated based on the latest available evidence. Any updated recommendations will always display the date of the most recent revision in the MAGICapp platform. With each update, a new PDF version of the consolidated guidelines will also be available for download on the WHO website. This version of the Guidelines includes updates to the case management of malaria, specifically the addition of new molecules for the treatment of uncomplicated malaria and optimization of the dosage regimen for anti-relapse treatment, along with updates on the use of antimalarial medicines in special risk populations including pregnant women. more

Download (289)

View PDF (385)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Managing epidemics: key facts about major deadly diseases, 2nd edition

World Health Organisation (WHO) (2023) C_WHO

Epidemics and pandemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of t... more

Managing epidemics: key facts about major deadly diseases, 2nd edition

World Health Organisation (WHO) (2023) C_WHO

Epidemics and pandemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of t... more

Download (217)

View PDF (197)

Policy brief on tuberculosis-associated disability

World Health Organization WHO (2023) C_WHO

People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include t... more

External Link

Cholera: Introduction Online Course
recommended

World Health Organization WHO (2019) C_WHO

Cholera is an acute diarrhoeal infection caused by ingestion of contaminated water or food. This course provides a general introduction to cholera and is intended for personnel responding to outbreaks in complex emergencies or in settings where the ... more

Download (162)

View PDF (320)

Guidelines for drinking-water quality: Small water supplies

World Health Organization WHO (2024) C_WHO

Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs and opportunities associated with these supplies therefore warrant explicit consideration in policies and regulati... more

External Link

Холера: Вступ
recommended

World Health Organization WHO (2019) C_WHO

Цей ознайомлювальний курс надає загальний огляд холери, включаючи принципи профілактики та боротьби з нею. Крім того, учасники курсу дізнаються про Глобальну робо... more

Zika Virus Infection: Step by Step Guide on Risk Communication and Community Engagement recommended

WHO Guidelines for malaria recommended

Cholera: Introduction Online Course recommended

Холера: Вступ recommended

Zika Virus Infection: Step by Step Guide on Risk Communication and Community Engagement
recommended

WHO Guidelines for malaria
recommended

Cholera: Introduction Online Course
recommended

Холера: Вступ
recommended